Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
華爾街最準確的分析師聚焦於3只醫療保健股票，提供高股息收益。
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市場動盪和不確定時期，許多投資者會選擇高股息股票。這些公司通常具有高自由現金流，並以高股息回報股東。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga讀者可以通過訪問分析師股票評級頁面，查看他們最喜歡的股票的最新分析師觀點。交易者可以瀏覽Benzinga廣泛的分析師評級數據庫，包括根據分析師準確性進行排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是醫療保健板塊三隻高收益股票最準確的分析師的評級。
Amgen Inc. (NASDAQ:AMGN)
AMGEN-T（納斯達克：AMGN）
- Dividend Yield: 3.67%
- Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price target from $344 to $310 on Jan. 2. This analyst has an accuracy rate of 66%.
- B of A Securities analyst Tim Anderson reinstated an Underperform rating with a price target of $256 on Dec. 10. This analyst has an accuracy rate of 63%.
- Recent News: On Dec. 10, Amgen increased its first-quarter dividend by 6% from $2.25 to $2.38 per share.
- Benzinga Pro's real-time newsfeed alerted to latest AMGN news.
- 股息收益率：3.67%
- 派傑投資分析師大衛·阿姆斯勒維持了增持評級，並在1月2日將目標價格從344美元下調至310美元。該分析師的準確率爲66%。
- 美銀證券分析師蒂姆·安德森於12月10日重新給予了表現落後評級，並設定了256美元的目標價格。該分析師的準確率爲63%。
- 最新資訊：安進於12月10日將其第一季度的股息從每股2.25美元增加了6%，達到每股2.38美元。
- Benzinga Pro的實時資訊源提醒了最新的安進新聞。
AbbVie Inc. (NYSE:ABBV)
艾伯維公司 (紐交所:ABBV)
- Dividend Yield: 3.66%
- B of A Securities analyst Tim Anderson reinstated a Neutral rating with a price target of $191 on Dec. 10. This analyst has an accuracy rate of 63%.
- Leerink Partners analyst David Risinger upgraded the stock from Market Perform to Outperform with a price target of $206 on Nov. 22. This analyst has an accuracy rate of 75%.
- Recent News: On Dec. 13, AbbVie announced plans to acquire Nimble Therapeutics.
- Benzinga Pro's real-time newsfeed alerted to latest ABBV news
- 股息收益率：3.66%
- 美銀證券的分析師TIM安德森在12月10日恢復了中立評級，目標價格爲191美元。該分析師的準確率爲63%。
- Leerink Partners的分析師大衛·瑞辛格將股票評級從市場表現上調至跑贏市場，目標價格爲206美元，日期爲11月22日。該分析師的準確率爲75%。
- 近期資訊：艾伯維公司於12月13日宣佈計劃收購Nimble Therapeutics。
- Benzinga Pro的實時資訊源提醒了最新的艾伯維公司新聞。
CVS Health Corporation (NYSE:CVS)
西維斯健康公司（紐約證券交易所股票代碼：CVS）
- Dividend Yield: 6.02%
- Deutsche Bank analyst George Hill upgraded the stock from Hold to Buy with a price target of $66 on Dec. 3. This analyst has an accuracy rate of 60%.
- Truist Securities analyst David Macdonald reiterated a Buy rating and lowered the price target from $76 to $67 on Nov. 20. This analyst has an accuracy rate of 63%.
- Recent News: The DOJ recently alleged that CVS violated the Controlled Substances Act by filling unlawful prescriptions for opioid combinations and excessive quantities since 2013.
- Benzinga Pro's charting tool helped identify the trend in CVS stock.
- 股息收益率：6.02%
- 德意志銀行的分析師喬治·希爾在12月3日將該股票的評級從持有上調至買入，目標價格爲66美元。該分析師的準確率爲60%。
- Truist Securities的分析師大衛·麥克唐納在11月20日重申了買入評級，並將目標價格從76美元下調至67美元。該分析師的準確率爲63%。
- 最近的資訊：美國司法部最近指控西維斯健康違反《管控物質法》，自2013年以來非法開具含有阿片類藥物的處方並填充過量數量。
- Benzinga Pro的圖表工具幫助識別西維斯健康股票的趨勢。
Read More:
閱讀更多：
- How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings
- 如何在Acuity Brands股票公佈第一季度盈利前每月賺取500美元
資訊熱榜
更新時間